{"canonical":"https://abierto.us/vendors/collaborations-pharmaceuticals-inc-efjcll37kkh3","key":"EFJCLL37KKH3","name":"COLLABORATIONS PHARMACEUTICALS, INC.","uei":"EFJCLL37KKH3","city":"FUQUAY VARINA","state":"NC","awards":1,"obligated":"1999195.12","notices_won":12,"top_agency_name":"National Institutes of Health","top_naics":"541714","cage":"7BGW7","parent_name":"COLLABORATIONS PHARMACEUTICALS, INC.","also_known_as":[],"country":"USA","actions":2,"first_action":"2025-09-29","last_action":"2026-06-24","breakdowns":{"naics":[{"key":"541714","name":null,"awards":1,"obligated":"1999195.12"}],"places":[{"key":"NC","name":null,"awards":1,"obligated":"1999195.12"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"1999195.12"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"1999195.12"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"1999195.12"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"1999195.12"}],"product_service_codes":[{"key":"AN12","name":null,"awards":1,"obligated":"1999195.12"}]},"awards_list":[{"award_key":"CONT_AWD_75N93025C00039_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93025C00039_7529_-NONE-_-NONE-/","piid":"75N93025C00039","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"EFJCLL37KKH3","recipient_name":"COLLABORATIONS PHARMACEUTICALS, INC.","recipient_uei":"EFJCLL37KKH3","recipient_cage":"7BGW7","recipient_city":"FUQUAY VARINA","recipient_state":"NC","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2025-09-29","last_action_date":"2026-06-24","actions":2,"obligated":"1999195.12","current_total_value":"1999195.12","potential_total_value":"1999195.12","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":4,"description":"IS TO DEVELOP PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX BY DEMONSTRATING PYRONARIDINE AS A VIABLE SINGLE DOSE TREATMENT FOR EBOLA INFECTION IN NON-HUMAN PRIMATES TO JUSTIFY FURTHER IN VIVO STUDIES FOR U","method":null,"confidence":null,"evidence":null,"opportunity_key":"PHS20251","opportunity_title":"Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive HIV Detection"}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}